Gerresheimer AG, one of the leading global partners to the pharma and healthcare industry, has closed the 2011 financial year with strong growth in revenues and profits. “Our revenues and profits have developed very positively in 2011. Further growth is one of our objectives for 2012, particularly with our products for the convenient and safe administration of medications. We will also be pushing ahead with the expansion of our business in the emerging markets,” said Uwe Röhrhoff, CEO of Gerresheimer AG.
In the 2011 financial year (December 1, 2010 to November 30, 2011), Gerresheimer recorded substantial revenue growth of 6.8 percent to EUR 1094.7m. At constant exchange rates revenues grew by 7.8 percent. This positive revenue development was particularly evident in the companys core business of pharmaceutical primary packaging products and medical devices made of glass and plastics. The cosmetic glass’ revenue performance was also good.
“We achieved all of our objectives in 2011 and our position is better than ever before. We want our shareholders to participate in our Company’s success so we will be proposing a dividend of EUR 0.60 per share at the Annual General Meeting,” said Röhrhoff.
Outlook
For the financial year 2012 Gerresheimer is expecting growth in revenues at constant exchange rates of five to six percent. Assuming an average exchange rate of 1.00 Euro being equivalent to 1.30 US Dollar this translates into nominal revenue growth of seven to eight percent. The Company assumes an adjusted EBITDA margin of around 19.5 percent. Investments of around EUR 100 million are scheduled for 2012.
About Gerresheimer
Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. The Group realizes revenues of around one billion euros and has more than 10,000 employees at 45 locations in Europe, North and South America and Asia.